Fat Loss & Recomp

Peptides researched for fat-mass reduction, body recomposition, and lipolytic signalling. This goal page collects compounds investigated for their effects on adipose metabolism, including GLP-1 receptor agonists (semaglutide, tirzepatide, retatrutide), GH-fragment lipolytic peptides (Fragment 176-191, AOD-9604, tesamorelin), and dual/triple agonists targeting energy expenditure and substrate partitioning.